Showing results (131-140 of 249) with videos related to

Sort By:
Pageof 25
Cancer Immunology, Immunotherapy : CII|July 14, 2010
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible "hard" lesionsFederico Garrido, Ignacio Algarra, Angel M García-Lora
Oncoimmunology|August 2, 2014
A novel preclinical murine model of immune-mediated metastatic dormancyIrene Romero, Federico Garrido, Angel M Garcia-Lora
Cancer Research|November 21, 2014
Metastases in immune-mediated dormancy: a new opportunity for targeting cancerIrene Romero, Federico Garrido, Angel M Garcia-Lora
Plos One|September 10, 2009
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenaseRikke Baek Sørensen, Linda Berge-Hansen, Niels Junker, et al.
Oncoimmunology|July 14, 2025
ProS1-MerTK signaling in CD4 T cells: implications for TIL expansion and functionalityAnnina Kurzay, Sara Fresnillo Saló, Anne Rahbech, et al.
Oncoimmunology|May 8, 2015
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancerMads Duus Hjortsø, Stine Kiaer Larsen, Per Kongsted, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 RegimenRikke Andersen, Marco Donia, Eva Ellebaek, et al.
Cellular & Molecular Immunology|January 21, 2021
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapyPer Anderson, Natalia Aptsiauri, Francisco Ruiz-Cabello, et al.
Cytotherapy|May 1, 2010
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trialRedas Trepiakas, Annika Berntsen, Sine Reker Hadrup, et al.
Cancer Immunology, Immunotherapy : CII|December 17, 2004
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cellsEva Jiménez, Angel Garcia-Lora, Marisol Martinez, et al.
Pageof 25